Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: GlobalData
$125.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sarepta Therapeutics announces appointment of John Hodgman as Interim Chairman


Thursday, 31 Jul 2014 05:10pm EDT 

Sarepta Therapeutics Inc:Announces that John Hodgman, a member of Sarepta's board of directors, has been named interim chairman, effective July 30.William Goolsbee, chairman of the company's board of directors, has resigned as chairman and will continue to serve on the Sarepta board as an independent director. 

Company Quote

13.21
-0.59 -4.28%
19 Dec 2014